Cannabis terpenes, the part of the plant which provides aroma and flavor, may provide therapeutic benefits in controlling pain, a new study reports.
A newly developed cannabidiol capsule can be absorbed by the body faster and penetrate the brain more quickly in mouse models of neurological disorders such as Alzheimer's disease, multiple sclerosis and TBI.
A new case study reveals medical marijuana may provide rapid relief for sufferers of chronic itch. Researchers say THC attaches itself to brain receptors that influence the nervous system. This reduces inflammation and nervous system activity, leading to a reduction in itch sensation.
Ninety percent of medical marijuana products offered at dispensaries are far stronger than recommended for chronic pain relief.
Every month, up to 6.4 million searches related to cannabidiol (CBD) are performed by American adults looking to obtain information or buy products. CBD search queries eclipse those for other natural medical alternatives by a significant percentage.
37% of Millenials and 25% of Gen Xers say they have used cannabinoids to help relieve pain.
The cannabis plant creates anti-inflammatory and pain-relieving molecules that are 30 times more powerful than Aspirin.
Children with drug-resistant epilepsy may find relief with the help of medical cannabis oil that contains both CBD and lose dose THC. The oil, which contains 95% CBD and 5% THC, can reduce or prevent epileptic seizures in those with epileptic encephalopathy.
Cannabis use in older people is growing faster than any other age group in Colorado. However, many report they face barriers in getting access to medical marijuana. Due to the stigma attached to cannabis use, many older people report feeling self-conscious about asking their health care providers for a red card to obtain medical marijuana.
H2CBD, a synthetic version of the cannabis compound CBD, has been found to be effective in decreasing the number and severity of seizures in rats.
A new study reveals the potency of THC in both herbal cannabis and cannabis resin has increased significantly in Europe since 2006.
A new study reveals cannabinoid medications may not reduce pain itself, but instead make pain feel less unpleasant and more tolerable.
